Yellow Fever Vaccine Market Insights Highlighting Opportunities Supporting Growth To 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Yellow Fever Vaccine Market In 2026, And How Will Its Value Evolve By 2030?
The yellow fever vaccine market size has shown consistent expansion in recent years. It is projected to increase from $4.74 billion in 2025 to $4.97 billion in 2026, advancing at a compound annual growth rate (CAGR) of 4.8%. The growth observed in the preceding period can be linked to recurrent yellow fever outbreaks, government-issued immunization mandates, established vaccine efficacy, international travel requirements, and various public health initiatives.
The yellow fever vaccine market size is anticipated to experience consistent expansion over the coming years. This market is projected to reach $5.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. The expansion during this forecast period stems from factors such as climate-driven mosquito propagation, an increase in global travel, the broadening of vaccination infrastructure, enhanced funding for disease prevention, and improved outbreak readiness. Prominent trends expected within the forecast timeframe encompass the expansion of routine immunization initiatives, an escalating demand from international travelers, a rise in government-led vaccination drives, the increasing adoption of single-dose vaccines, and a concentrated effort on preventing endemic diseases.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp
Which Key Drivers Are Affecting The Yellow Fever Vaccine Market Development?
The yellow fever vaccine market is anticipated to expand, propelled by the rise in international travel. International travel involves individuals journeying across national borders for tourism, business, or personal reasons. This increase in international travel is driven by growing global mobility, bolstered by economic recovery and the relaxation of post-pandemic travel restrictions. The yellow fever vaccine market supports travelers by offering mandatory or recommended immunization for entry into regions where yellow fever is endemic. For instance, in January 2024, according to the World Tourism Organization (UNWTO), a Spain-based international tourism agency, global international tourist arrivals reached 1.286 billion in 2023, marking an increase from 0.96 billion in 2022, which represents a rise of 0.326 billion international tourists year-on-year. Consequently, increasing international travel is a primary driver for the growth of the yellow fever vaccine market.
How Are Different Segments Classified In The Yellow Fever Vaccine Market Segment Analysis?
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Application: Routine Immunization, Travelers, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
What Trends Are Transforming The Yellow Fever Vaccine Market?
Major companies in the yellow fever vaccine market are increasingly directing their efforts towards developing innovative solutions, such as T-cell adaptive booster vaccines, to strengthen long-term immunity, boost vaccine efficacy, and overcome the shortcomings of traditional live-attenuated vaccines. T-cell adaptive booster vaccines are formulated to fortify the immune system by specifically enhancing T-cell responses, which enable the body to detect and combat infections more effectively compared to conventional antibody-focused vaccines. For instance, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare provider, launched Yellow Fever Vaccination services to offer travelers protection against the mosquito-borne viral disease and to issue the internationally recognized vaccination certificate. This program aims to expand access to the vaccine within Telangana, thereby reducing the requirement for lengthy journeys to other authorized centers. Moreover, the initiative ensures adherence to international health regulations by providing safe administration under medical supervision, particularly for those with contraindications.
Who Are The Companies Driving Activity In The Yellow Fever Vaccine Market?
Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated
Get The Full Yellow Fever Vaccine Market Report:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Which Region Has The Greatest Market Share In The Yellow Fever Vaccine Market?
North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Yellow Fever Vaccine Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company
Yellow Fever Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Yellow Fever Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
